Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Melatonin Use in Patients With Climacterious Symptoms in the Perimenopause
- First Posted Date
- 2024-01-05
- Last Posted Date
- 2024-01-05
- Lead Sponsor
- Univates
- Target Recruit Count
- 40
- Registration Number
- NCT06192641
- Locations
- 🇧🇷
Gabriela Laste, Lajeado, Rio Grande Do Sul, Brazil
News
No news found